- FIS is based in Vicenza, Italy
- NTG is the holding company of the Ferrari Family
- Bain Capital is a private investment firm with $165bn of assets under management
Bain Capital Private Equity has agreed to buy Fabbrica Italiana Sintetici (FIS), a developer and manufacturer of small molecule active pharmaceutical ingredients (APIs) and intermediates, from Nine Trees Group (NTG).
No financial details of the transaction were disclosed.
FIS is based in Vicenza, Italy and is founded by the Ferrari family. The company, in 2022, generated sales of around €700 million.
“Our investment in FIS marks a strategically important transaction for Bain Capital Private Equity in Europe, consistent with our thematic investment approach to the pharmaceutical industry,” said Christina Dix and Benjamin Kunstler, partners, and co-heads of European healthcare at Bain Capital Private Equity.
The transaction is subject to relevant regulatory approvals.
NTG is the holding company of the Ferrari Family.
Bain Capital is a private investment firm with $165 billion of assets under management. The firm is based in Boston, US.
Bain Capital has been advised by Mediobanca, Nomura, Latham & Watkins, Advancy, Bain & Company, PwC, Pirola Pennuto Zei & Associati and InterPharmaLink.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: 
